strabismus. Strabismus, unspecified
Conditions
Interventions
Intervention 1: Control group: they received 3.5 ml distilled water as placebo before propofol injection. Intervention 2: Intervention group 1 : received intravenous lidocaine 2% (1.5mg/kg ) before pr
Placebo
Treatment - Drugs
Control group: they received 3.5 ml distilled water as placebo before propofol injection
Intervention group 1 : received intravenous lidocaine 2% (1.5mg/kg ) before propofol injection
Intervention group 2 : received intravenous hyoscine buthylbromide (0.2 mg/kg) before propofol injection
Sponsors
Vice Chancellor for Research, Mashhad University of Medical Science
Eligibility
Sex/Gender
All
Age
5 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients undergoing strabismus surgery; no history of previous strabismus surgery; both sexes; American Society of Anesthesiology (ASA) I; age between 5-30 years Exclusion criteria: American Society of Anesthesiology (ASA) II and higher; hypertension; coronary artery disease; respiratory disease; diabetes; addiction; use of beta-blocker drugs before surgery; hyoscine and lidocaine allergy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Before induction, after induction, after LMA insertion, start time of surgery, before and after muscle traction. Method of measurement: Intraoperative monitoring.;Dysrhythmia. Timepoint: Before induction, after induction, after LMA insertion, start time of surgery, before and after muscle traction. Method of measurement: Intraoperative monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before induction, after induction, after LMA insertion, start time of surgery, before and after muscle traction. Method of measurement: Intraoperative monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehryar Taghavi Gilani
Mashhad University of Medical Sciences
Outcome results
None listed